{"count": 6, "results": [{"_id": "40531218", "pmid": 40531218, "title": "Genetic insights into the effect of Metformin on psychiatry disorders.", "journal": "Eur Arch Psychiatry Clin Neurosci", "authors": ["Zhou Q", "Du Z", "Lu R", "Shen Y", "Jiang Y", "Zhu H"], "date": "2025-08-01T00:00:00Z", "doi": "10.1007/s00406-025-02039-3", "meta_date_publication": "2025 Aug", "meta_volume": "275", "meta_issue": "5", "meta_pages": "1465-1476", "score": 50279.02, "text_hl": "Genetic insights into the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on @<m>DISEASE_Congenital_Hereditary_and_Neonatal_Diseases_and_Abnormalities</m> @DISEASE_MESH:D009358 @@@psychiatry disorders@@@.", "citations": {"NLM": "Zhou Q, Du Z, Lu R, Shen Y, Jiang Y, Zhu H. Genetic insights into the effect of Metformin on psychiatry disorders. Eur Arch Psychiatry Clin Neurosci. 2025 Aug;275(5):1465-1476. PMID: 40531218", "BibTeX": "@article{40531218, title={Genetic insights into the effect of Metformin on psychiatry disorders.}, author={Zhou Q and Du Z and Lu R and Shen Y and Jiang Y and Zhu H}, journal={Eur Arch Psychiatry Clin Neurosci}, volume={275}, number={5}, pages={1465-1476}}"}}, {"_id": "35367225", "pmid": 35367225, "title": "Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder.", "journal": "Mech Ageing Dev", "authors": ["Trujillo-Del Río C", "Tortajada-Pérez J", "Gómez-Escribano AP", "Casterá F", "Peiró C", "Millán JM", "Herrero MJ", "Vázquez-Manrique RP"], "date": "2022-06-01T00:00:00Z", "doi": "10.1016/j.mad.2022.111670", "meta_date_publication": "2022 Jun", "meta_volume": "204", "meta_issue": "", "meta_pages": "111670", "score": 50267.633, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ to treat @DISEASE_Huntington_Disease @DISEASE_MESH:D006816 @@@Huntington disease@@@: A pleiotropic drug against a multi-system @<m>DISEASE_Congenital_Hereditary_and_Neonatal_Diseases_and_Abnormalities</m> @DISEASE_MESH:D009358 @@@disorder@@@.", "citations": {"NLM": "Trujillo-Del Río C, Tortajada-Pérez J, Gómez-Escribano AP, Casterá F, Peiró C, Millán JM, Herrero MJ, Vázquez-Manrique RP. Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder. Mech Ageing Dev. 2022 Jun;204():111670. PMID: 35367225", "BibTeX": "@article{35367225, title={Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder.}, author={Trujillo-Del Río C and Tortajada-Pérez J and Gómez-Escribano AP and Casterá F and Peiró C and Millán JM and Herrero MJ and Vázquez-Manrique RP}, journal={Mech Ageing Dev}, volume={204}, pages={111670}}"}}, {"_id": "37457314", "pmid": 37457314, "pmcid": "PMC10338908", "title": "Metformin improves fibroblast metabolism and ameliorates arthrofibrosis in rats", "journal": "J Orthop Translat", "authors": ["Zhu Z", "Gao S", "Zhu H", "Chen Y", "Wu D", "Chen Z", "Huang Y", "Wu X", "Hu N", "Chen D", "Huang W", "Chen H"], "date": "2023-06-12T00:00:00Z", "doi": "10.1016/j.jot.2023.05.011", "meta_date_publication": "2023 May", "meta_volume": "40", "meta_issue": "", "meta_pages": "92-103", "score": 50254.14, "text_hl": "The metabolic modulator @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ appears to be a therapeutic candidate for @<m>DISEASE_Congenital_Hereditary_and_Neonatal_Diseases_and_Abnormalities</m> @DISEASE_MESH:D009358 @@@fibrotic disorders@@@. ", "citations": {"NLM": "Zhu Z, Gao S, Zhu H, Chen Y, Wu D, Chen Z, Huang Y, Wu X, Hu N, Chen D, Huang W, Chen H. Metformin improves fibroblast metabolism and ameliorates arthrofibrosis in rats J Orthop Translat. 2023 May;40():92-103. PMID: 37457314", "BibTeX": "@article{37457314, title={Metformin improves fibroblast metabolism and ameliorates arthrofibrosis in rats}, author={Zhu Z and Gao S and Zhu H and Chen Y and Wu D and Chen Z and Huang Y and Wu X and Hu N and Chen D and Huang W and Chen H}, journal={J Orthop Translat}, volume={40}, pages={92-103}}"}}, {"_id": "36322951", "pmid": 36322951, "title": "Therapeutic metformin concentrations positively regulate proliferation in endometrial epithelial cells via mTOR activation and augmented mitochondrial strength.", "journal": "Can J Physiol Pharmacol", "authors": ["Imran M", "Sachdeva G", "Menon S", "Das D", "Davuluri S", "Acharya K", "Chaudhari U"], "date": "2023-01-01T00:00:00Z", "doi": "10.1139/cjpp-2022-0307", "meta_date_publication": "2023 Jan 1", "meta_volume": "101", "meta_issue": "1", "meta_pages": "52-64", "score": 50244.082, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, an antidiabetic drug, has recently been repositioned in the treatment of several @<m>DISEASE_Congenital_Hereditary_and_Neonatal_Diseases_and_Abnormalities</m> @DISEASE_MESH:D009358 @@@nondiabetic disorders@@@, including @DISEASE_Reproductive_Tract_Infections @DISEASE_MESH:D060737 @@@reproductive disorders@@@ such as @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovarian syndrome@@@, where it improves endometrial functions. ", "citations": {"NLM": "Imran M, Sachdeva G, Menon S, Das D, Davuluri S, Acharya K, Chaudhari U. Therapeutic metformin concentrations positively regulate proliferation in endometrial epithelial cells via mTOR activation and augmented mitochondrial strength. Can J Physiol Pharmacol. 2023 Jan 1;101(1):52-64. PMID: 36322951", "BibTeX": "@article{36322951, title={Therapeutic metformin concentrations positively regulate proliferation in endometrial epithelial cells via mTOR activation and augmented mitochondrial strength.}, author={Imran M and Sachdeva G and Menon S and Das D and Davuluri S and Acharya K and Chaudhari U}, journal={Can J Physiol Pharmacol}, volume={101}, number={1}, pages={52-64}}"}}, {"_id": "37302126", "pmid": 37302126, "title": "[Investigation of glycaemic and nutritional status of patients suffering from cancer.]", "journal": "Orv Hetil", "authors": ["Bánhegyi RJ", "Veréb B", "Mátrai ÁA", "Rácz B", "Beke S"], "date": "2023-06-11T00:00:00Z", "doi": "10.1556/650.2023.32796", "meta_date_publication": "2023 Jun 11", "meta_volume": "164", "meta_issue": "23", "meta_pages": "900-910", "score": 50236.03, "text_hl": "CONCLUSION: Based on our results, targeted screening for @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ among @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@, and seeking and adequately treating @<m>DISEASE_Congenital_Hereditary_and_Neonatal_Diseases_and_Abnormalities</m> @DISEASE_MESH:D009358 @@@glycometabolic disorders@@@ with concomitant malignant conditions, respectively , are suggested, mainly using @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and new non-@CHEMICAL_Insulin @CHEMICAL_MESH:D007328 @@@insulin@@@ antidiabetic medicines. ", "citations": {"NLM": "Bánhegyi RJ, Veréb B, Mátrai ÁA, Rácz B, Beke S. [Investigation of glycaemic and nutritional status of patients suffering from cancer.] Orv Hetil. 2023 Jun 11;164(23):900-910. PMID: 37302126", "BibTeX": "@article{37302126, title={[Investigation of glycaemic and nutritional status of patients suffering from cancer.]}, author={Bánhegyi RJ and Veréb B and Mátrai ÁA and Rácz B and Beke S}, journal={Orv Hetil}, volume={164}, number={23}, pages={900-910}}"}}, {"_id": "26997714", "pmid": 26997714, "pmcid": "PMC4778205", "title": "Metformin - For the dermatologist", "journal": "Indian J Pharmacol", "authors": ["Bubna AK"], "date": "2016-01-01T00:00:00Z", "doi": "10.4103/0253-7613.174388", "meta_date_publication": "2016 Jan-Feb", "meta_volume": "48", "meta_issue": "1", "meta_pages": "4-10", "score": 50078.605, "text_hl": "...Mechanism of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Congenital_Hereditary_and_Neonatal_Diseases_and_Abnormalities</m> @DISEASE_MESH:D009358 @@@hyperpigmentary disorders@@@", "citations": {"NLM": "Bubna AK. Metformin - For the dermatologist Indian J Pharmacol. 2016 Jan-Feb;48(1):4-10. PMID: 26997714", "BibTeX": "@article{26997714, title={Metformin - For the dermatologist}, author={Bubna AK}, journal={Indian J Pharmacol}, volume={48}, number={1}, pages={4-10}}"}}]}